Clarus Lifesciences III, L.P., 10% Owner at Gritstone Oncology, Inc. (GRTS), bought 2,567,445 shares at $15.00 ($5.0M) on 2018-09-28, disclosed to the SEC on 2018-10-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 333,333 | $5.0M | 100.0% |
| 2 | $0.00 | 2,234,112 | $0 | 0.0% |
| Total | $1.95 avg | 2,567,445 | $5.0M | 100% |